ouabain has been researched along with phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castes, E; Devillers, JP; Labrouche, SA; Simonnet, G | 1 |
1 other study(ies) available for ouabain and phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
| Article | Year |
|---|---|
Release of neuropeptide FF, an anti-opioid peptide, in rat spinal cord slices is voltage- and Ca(2+)-sensitive: possible involvement of P-type Ca2+ channels.
Topics: Animals; Calcium; Calcium Channels; Electrophysiology; Endorphins; In Vitro Techniques; Male; Oligopeptides; Ouabain; Perfusion; Potassium; Radioligand Assay; Rats; Rats, Wistar; Spinal Cord; Veratridine | 1995 |